Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)
- Authors
- Kim, HR[Kim, H. R.]; Jung, KH[Jung, K. H.]; Im, SA[Im, S. -A.]; Im, YH[Im, Y. -H.]; Kang, SY[Kang, S. Y.]; Park, KH[Park, K. H.]; Lee, S[Lee, S.]; Kim, SB[Kim, S. -B.]; Lee, KH[Lee, K. -H.]; Ahn, JS[Ahn, J. S.]; Kim, SI[Kim, S. I.]; Sohn, JH[Sohn, J. H.]
- Issue Date
- Jun-2013
- Publisher
- OXFORD UNIV PRESS
- Keywords
- bevacizumab; carboplatin; docetaxel; neoadjuvant c
- Citation
- ANNALS OF ONCOLOGY, v.24, no.6, pp.1485 - 1490
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 24
- Number
- 6
- Start Page
- 1485
- End Page
- 1490
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/60379
- DOI
- 10.1093/annonc/mds658
- ISSN
- 0923-7534
- Abstract
- Background: This phase II neoadjuvant trial evaluated bevacizumab docetaxel and carboplatin in triple-negative breast cancer. Patients and methods: Women with hormone receptor- and human epidermal growth factor receptor 2 (HER2)-negative, stage II/III breast cancer received six cycles of 75 mg/m(2) docetaxel, carboplatin (AUG = 5) and 15 mg/kg bevacizumab every 21 days. The primary end point was pathological complete response (pCR) in breasts and axillary lymph nodes (ALN). Results: Forty-five patients were recruited from the Korean Cancer Study Group. The median age was 45 (range 30-72) years. ALNs were positive in 80% of patients (n = 36) at diagnosis. Overall, 98% of patients (n = 44) completed therapy and underwent surgery. The pCR rate was 42% (n = 19); clinical response rate 96% (n = 43); complete 13% (n = 6); partial 82% (n = 37); stable disease 2% (n = 1). Breast-conserving surgery was undertaken in 78% of patients (n = 35). Most frequent grade 3/4 adverse events were neutropenia (84%, n = 38) and febrile neutropenia (9%, n = 4). One patient experienced delayed wound healing after surgery. Conclusions: Neoadjuvant bevacizumab, docetaxel and carboplatin resulted in an encouraging pCR rate and negligible wound healing problems after surgery.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.